Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,463 | 97 | 68.3% |
| Consulting Fee | $47,886 | 24 | 12.7% |
| Food and Beverage | $29,709 | 1,076 | 7.9% |
| Travel and Lodging | $21,824 | 91 | 5.8% |
| Honoraria | $20,060 | 13 | 5.3% |
| Education | $505.60 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $131,601 | 225 | $0 (2024) |
| Celgene Corporation | $60,010 | 120 | $0 (2019) |
| Amgen Inc. | $48,444 | 72 | $0 (2024) |
| UCB, Inc. | $47,803 | 71 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $22,229 | 41 | $0 (2021) |
| Almirall LLC | $21,308 | 45 | $0 (2022) |
| LEO Pharma Inc. | $13,140 | 62 | $0 (2024) |
| Allergan, Inc. | $11,419 | 23 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $6,297 | 23 | $0 (2024) |
| EPI Health, LLC | $3,666 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113,489 | 225 | Galderma Laboratories, L.P. ($53,957) |
| 2023 | $76,293 | 213 | Galderma Laboratories, L.P. ($54,667) |
| 2022 | $31,613 | 135 | Galderma Laboratories, L.P. ($17,910) |
| 2021 | $23,919 | 156 | VYNE Pharmaceuticals Inc. ($12,921) |
| 2020 | $25,071 | 122 | Amgen Inc. ($13,102) |
| 2019 | $50,478 | 171 | Celgene Corporation ($31,808) |
| 2018 | $29,977 | 150 | Celgene Corporation ($12,950) |
| 2017 | $27,608 | 140 | Celgene Corporation ($15,252) |
All Payment Transactions
1,312 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| 12/27/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $14.74 | General |
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.20 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $149.85 | General |
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.99 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 11/13/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.47 | General |
| 11/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $44.95 | General |
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.49 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation & Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,121 | 1,976 | $380,894 | $79,631 |
| 2022 | 12 | 1,082 | 1,890 | $298,456 | $83,556 |
| 2021 | 14 | 1,008 | 1,758 | $203,058 | $76,725 |
| 2020 | 11 | 952 | 1,632 | $181,580 | $60,744 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 50 | $5,747 | $1,944 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 248 | 312 | $43,992 | $17,458 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 107 | $22,256 | $9,862 | 44.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 128 | 147 | $27,930 | $9,609 | 34.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 148 | 200 | $25,800 | $7,607 | 29.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 61 | 95 | $18,525 | $7,469 | 40.3% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 21 | 25 | $14,525 | $6,041 | 41.6% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 21 | 28 | $8,092 | $3,301 | 40.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $8,987 | $2,989 | 33.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 99 | 610 | $6,710 | $2,855 | 42.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $7,383 | $2,773 | 37.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 70 | 76 | $6,384 | $2,672 | 41.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 39 | 64 | $6,528 | $2,574 | 39.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 17 | 17 | $2,448 | $764.92 | 31.2% |
| 11402 | Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 11 | 11 | $3,498 | $749.21 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 208 | 226 | $47,008 | $15,337 | 32.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 137 | 150 | $28,500 | $9,528 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 143 | 195 | $27,495 | $9,320 | 33.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 142 | 182 | $23,478 | $6,235 | 26.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 61 | 77 | $15,015 | $5,898 | 39.3% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 25 | 25 | $14,525 | $5,463 | 37.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 108 | 629 | $6,919 | $2,606 | 37.7% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 59 | 59 | $8,496 | $2,498 | 29.4% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 32 | 51 | $5,202 | $2,075 | 39.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,926 | $1,179 | 40.3% |
About Dr. Joshua Grosshandler, M.D
Dr. Joshua Grosshandler, M.D is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023320389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Grosshandler, M.D has received a total of $378,447 in payments from pharmaceutical and medical device companies, with $113,489 received in 2024. These payments were reported across 1,312 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,463).
As a Medicare-enrolled provider, Grosshandler has provided services to 4,163 Medicare beneficiaries, totaling 7,256 services with total Medicare billing of $300,657. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 07/02/2010
- Last Updated 02/06/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1023320389
Products in Payments
- Otezla (Drug) $107,923
- AKLIEF (Drug) $53,010
- Bimzelx (Biological) $43,486
- EPSOLAY (Drug) $18,424
- Seysara (Drug) $14,749
- ZILXI (Drug) $12,921
- PICATO (Drug) $12,336
- AMZEEQ (Drug) $9,307
- ORACEA (Drug) $5,977
- SEYSARA (Drug) $5,174
- WYNZORA (Drug) $3,400
- ACZONE (Drug) $2,420
- RHOFADE (Drug) $2,133
- SKYRIZI (Biological) $1,150
- Sotyktu (Drug) $1,141
- DUPIXENT (Biological) $1,018
- Klisyri (Drug) $823.29
- Cimzia (Drug) $754.21
- TALTZ (Drug) $736.78
- RINVOQ (Biological) $723.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Sara Huff, Md, MD
Dermatology — Payments: $5,661